Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
- If taking medications indicated for control of AD symptoms, on stable doses for at least 8 weeks prior to screening Exclusion criteria - Any history of bipolar affective disorder - A medical condition, other than AD, that may contribute to the individuals cognitive impairment - Stroke or transient ischemic attack in the past 12 months - Clinically significant unstable psychiatric condition in the past 6 months - Inability to swallow oral medications - Other medical conditions which the investigator deems would limit the individuals life expectancy to less than 6 months - Concurrent use of anti-depressant medication - Participation in another interventional clinical trial, or intake of another investigations drug within 4 weeks or 5 half-lives (whichever is longer) Study Estimands Primary estimand 1
GHK-Cu is a tripeptide-copper complex consisting of glycine-histidine-lysine bound to a copper(II) ion, available as a lyophilized powder for laboratory research
Does THE GLOW replace skincare or a healthy diet
Reading product labels and consulting with a healthcare professional before using any new products is advisable, as some topical skin care products may contain ingredients that could cause skin irritation or allergic reactions
doi:10.1093/BMB/LDR030 6
US$ 23.95
US$ 24.96
US$ 25.86
US$ 25.71
US$ 26.22
